Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Cancer Res Ther ; 18(6): 1537-1540, 2022.
Article in English | MEDLINE | ID: mdl-36412406

ABSTRACT

Objective: To find out the epidemiological factors and oncology treatment outcome in human immunodeficiency virus-positive cancer cervix patients (HPCCP). Materials and Methods: After institutional ethics committee approval, hospital case records of HPCCP registered at the radiation oncology department from January 2011 to December 2018 were retrospectively studied. Results: The case records of 22 eligible HPCCP were studied. Median age at presentation was 42.5 years. 90.90% of the patients were below 55 years of age. The duration of symptom was <3 months in 63.64% of patients. 68.18% of the patients were FIGO Stage III. Only 11 patients completed the planned treatment. Total target equivalent dose of 2 Gy per fraction delivered was 66 Gy. Seven patients had complete response. Four patients had local recurrence. Median disease-free and overall survival was 27 (14-38) and 18 months (2-48), respectively. Conclusion: HPCCP present at relatively early age and advanced stage despite short symptom duration. Poor patient compliance and treatment alteration have led to suboptimal outcome.


Subject(s)
HIV Seropositivity , Uterine Cervical Neoplasms , Female , Humans , Adult , Retrospective Studies , Cervix Uteri , Uterine Cervical Neoplasms/radiotherapy , Uterine Cervical Neoplasms/drug therapy , Treatment Outcome , HIV
2.
J Cancer Res Ther ; 18(6): 1572-1577, 2022.
Article in English | MEDLINE | ID: mdl-36412413

ABSTRACT

Aim: This study aims to evaluate the efficacy, feasibility, tolerability, and toxicity of concurrent chemotherapy and brachytherapy for locally advanced cervical carcinoma. Materials and Methods: Forty patients of cervical carcinoma were included in this study. The study period ranges from October 2016 to September 2019. Patients were evaluated and treated as per the protocol: external beam radiotherapy (50 Gy in 25 fractions) and concurrent weekly chemotherapy with injection (Inj.) cisplatin (30 mg/m2) followed by high-dose rate brachytherapy (3 fractions of 7 Gy each) and concurrent chemotherapy Inj. cisplatin (30 mg/m2). Results: Out of 40 patients enrolled in the study, 36 patients completed the treatment (17 Stage II and 19 Stage III). The incidence of Grade I and II skin toxicities were 78% and 10%, respectively. The incidence of genitourinary toxicities with respect to Grade I and II were 72% and 12%, respectively. There were Grade III hematological toxicities in two patients and the brachytherapy treatment was delayed for 4-6 days. The overall complete response was found in 28 (78%) patients, partial response in six (16.7%) patients, and progressive disease in two (5.6%) patients at 3 months of follow-up. On the last follow-up, 21 (58%) patients were disease-free and there was disease failure in seven patients (5 local recurrence and 2 with distant metastasis). Conclusion: Brachytherapy with the addition of concurrent chemotherapy is effective and feasible with acceptable toxicity for advanced stages of carcinoma cervix. This study upholds an interesting approach that can be regarded as feasible and tolerable for cervical cancer patients.


Subject(s)
Brachytherapy , Testicular Neoplasms , Uterine Cervical Neoplasms , Female , Male , Humans , Brachytherapy/adverse effects , Cervix Uteri , Cisplatin/adverse effects , India/epidemiology , Chemoradiotherapy/adverse effects , Uterine Cervical Neoplasms/therapy
3.
J Cancer Res Ther ; 15(1): 104-107, 2019.
Article in English | MEDLINE | ID: mdl-30880763

ABSTRACT

BACKGROUND: Gastrointestinal (GI) malignancies are increasing with advancing age. Various addictions and poor dietary habits are among the major risk factors. Early detection is difficult until patient notices symptoms. Primary prevention by knowing various risk factors and early symptom awareness will help in early diagnosis and better treatment outcome. OBJECTIVES: This study is carried out to see various addiction patterns, dietary habits, associated medical problems, and socioeconomic status with various sites involved in GI malignancies, at a tertiary care teaching hospital of Western Maharashtra, India. MATERIALS AND METHODS: Prospective questionnaire-based study was carried out for 11 months. A total of 100 diagnosed carcinoma cases of GI tract malignancy were taken for study. RESULTS AND CONCLUSIONS: Out of total 100 cases, 61 were male and 39 were female. The most common site involved was esophagus (41) followed by rectosigmoid, colon and cecum, stomach, and anal canal (29, 14, 13, and 3, respectively). There were 45% of cases above 60 years of age. The most common addiction was smokeless tobacco. Most of the patients belonged to lower and upper lower class (64%). Majority of cases (81%) were nonvegetarian, only 16% were pure vegetarian. Most of the cases (85%) were in advanced stage of disease (III and IV). Awareness program for harmful effects of various addictions and importance of high-fiber diet (vegetarian diet) will help in health promotion and prevention of various malignancies. Awareness about the early symptoms of GI malignancy will help in early detection of disease and better treatment outcome.


Subject(s)
Behavior, Addictive/epidemiology , Feeding Behavior , Gastrointestinal Neoplasms/epidemiology , Socioeconomic Factors , Adult , Aged , Aged, 80 and over , Female , Gastrointestinal Neoplasms/prevention & control , Health Knowledge, Attitudes, Practice , Health Promotion , Humans , India/epidemiology , Male , Middle Aged , Patient Education as Topic , Prospective Studies , Risk Factors , Rural Population/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data , Tobacco, Smokeless/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...